Onkaido Messenger Therapeutics Trademark Details

This mark is alive with a status of Published for Opposition. The last case file activity for this mark occured 7 years ago on Thursday, September 29, 2016, according to the United State Patent & Trademark Office
Word Mark Onkaido Messenger Therapeutics
Status Alive 686 — Published for Opposition

Current Owner

Moderna Therapeutics, Inc. of Cambridge, MA

View all trademarks for Moderna Therapeutics, Inc.
Other Trademarks for Moderna Therapeutics, Inc.
Serial Number 86980449
Status Date Thursday, September 29, 2016
Filing Date Thursday, September 29, 2016
Attorney Anessa Owen Kramer

Correspondent

Anessa Owen Kramer
Honigman Miller Schwartz and Cohn LLP
39400 Woodward Avenue, Suite 101
Bloomfield Hills, MI 48304-5151

Case File Statements

Disclaimer with Predetermined Text "Messenger Therapeutics"
Goods & Services Scientific research; scientific research in the fields of pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics for use in oncology

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Wednesday, February 5, 2014
First Use Anywhere Tuesday, January 14, 2014
First Use In Commerce Tuesday, January 14, 2014
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.